1-17 of 17
Jing Tang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT248: Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2 mutant non-small cell lung cancer (NSCLC): primary analysis from the Phase 2 DESTINY-Lung05 (DL-05) trial

Ying Cheng, Lin Wu, Yong Fang, Yun Fan, Xingya Li, Mingjun Zhang, Yan Yu, Yu Yao, Ruilian Xu, Jun Guo, Huaping Yang, Jian Fang, Feng Luo, Xuhong Min, Ke-jing Tang, Jie Hu, Yunru Chen, Rui Mao, Victor Zhang, Dairong Li
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT248.
https://doi.org/10.1158/1538-7445.AM2024-CT248
Published: 05 April 2024
View article titled, Abstract CT248: Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2 mutant non-small cell lung cancer (NSCLC): primary analysis from the Phase 2 DESTINY-Lung05 (DL-05) trial
Journal Articles

Abstract 3578: A systematic NEN spheroid drug screen reveals a novel drug resistance mechanism in small bowel NETs

Catherine G. Tran, Luis C. Borbon, Dane H. Tow, Jonathan Shilyansky, Guiying Li, James Egan, Scott K. Sherman, Ellen Abusada, Jing Tang, Ramaswamy govindan, Ryan C. Fields, Terry A. Braun, Carlos HF Chan, Chandrikha Chandrasekharan, Douglas Spitz, Dawn E. Quelle, Andrew M. Bellizzi, James R. Howe, Po Hien Ear
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3578.
https://doi.org/10.1158/1538-7445.AM2024-3578
Published: 22 March 2024
View article titled, Abstract 3578: A systematic NEN spheroid drug screen reveals a novel drug resistance mechanism in small bowel NETs
Journal Articles

Abstract 595: Preclinical development of the CDK4 selective inhibitor PF-07220060: Increased CDK4 versus CDK6 inhibition leads to improved anti-tumor efficacy at therapeutic concentrations

Lars Anders, Bernadette Pascual, Britton Boras, Julie Cianfrogna, Scott Garza, Na Li, Jing Tang Yuan, Mark Moen, Nanni Huser, Gary Gallego, Mehran Jalaie, Sacha Ninkovic, Sujin Cho-Schultz, Hong Shen, John Kath, Klaus Dress, Wade Diehl, Sajiv Nair, Rhys Jones, Jennifer Lafontaine, Anwar Murtaza, Aida Sacaan, Sudhakar Chintharlapalli, Todd VanArsdale
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 595.
https://doi.org/10.1158/1538-7445.AM2024-595
Published: 22 March 2024
View article titled, Abstract 595: Preclinical development of the CDK4 selective inhibitor PF-07220060: Increased CDK4 versus CDK6 inhibition leads to improved anti-tumor efficacy at therapeutic concentrations
Journal Articles

Abstract PR-007: Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer

Anniina Färkkilä, Ashwini S. Nagaraj, Elina A. Pietilä, Matilda Salko, Erdogan P. Erkan, Iga Niemiec, Aditi Sirsikar, Jie Bao, Giovanni Marchi, Kirsten Nowlan, Sampsa Hautaniemi, Anna Vähärautio, Jing Tang, Ulla-Maija Haltia, Eliisa Kekäläinen, Anni Virtanen, Tuula Salo
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): PR-007.
https://doi.org/10.1158/1538-7445.OVARIAN23-PR-007
Published: 04 March 2024
View article titled, Abstract PR-007: Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer
Journal Articles

Abstract B097: Image analysis-guided spatial transcriptomics improves recognition of biological features important for outcome in high grade serous carcinoma

Anna R. Laury, Shuyu Zheng, Niina Aho, Robin Fallegger, Satu M. Hänninen, Julio Saez Rodriguez, Jovan Tanevski, Omar Youssef, Jing Tang, Olli Carpén
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): B097.
https://doi.org/10.1158/1538-7445.OVARIAN23-B097
Published: 04 March 2024
View article titled, Abstract B097: Image analysis-guided spatial transcriptomics improves recognition of biological features important for outcome in high grade serous carcinoma
Journal Articles

The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression

Jing Tang, Shuoshuo Wang, Mingjiao Weng, Qingyu Guo, Lili Ren, Yan He, Zihan Cui, Mingqi Cong, Minglu Qin, Jia Yu, Rui Su, Xiaobo Li
Journal: Cancer Research
Cancer Res (2023) 83 (21): 3593–3610.
https://doi.org/10.1158/0008-5472.CAN-23-0557
Published: 01 November 2023
View article titled, The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression
Open the PDF for The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression in another window
Includes: Supplementary data
Journal Articles

Abstract 5507: A potential combinatorial treatment strategy to overcome olaparib resistance in high-grade ovarian cancer

Jie Bao, Eva Daniela Mendoza Ortiz, Jessica Agudelo, Roman Filimonov, Anniina Färkkilä, Jing Tang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5507.
https://doi.org/10.1158/1538-7445.AM2023-5507
Published: 04 April 2023
View article titled, Abstract 5507: A potential combinatorial treatment strategy to overcome olaparib resistance in high-grade ovarian cancer
Journal Articles

Abstract 5171: Gene expression in multi-parametric MRI visible and invisible prostate cancers predicts progression

Timo-Pekka K. Lehto, Carolin Stürenberg, Juho Pylväläinen, Kevin Sandeman, Anu Kenttämies, Stig Nordling, Jing Tang, Tuomas Mirtti, Antti Rannikko
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5171.
https://doi.org/10.1158/1538-7445.AM2022-5171
Published: 15 June 2022
View article titled, Abstract 5171: Gene expression in multi-parametric MRI visible and invisible prostate cancers predicts progression
Journal Articles

Abstract 320: 3D-bioprinting of biomimetic multicellular glioblastoma tissues enable modeling of tumor-immune interactions

Min Tang, Qi Xie, Ryan C. Gimple, Briana C. Prager, Zhixin Qiu, Jacob Schimelman, Pengrui Wang, Derrick Lee, Aaron Yu, Tyler E. Miller, Reilly L. Kidwell, Xueyi Wan, Jing Tang, Trevor Tam, Jing Tian, Bingjie Sun, Shaochen Chen, Jeremy Rich
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 320.
https://doi.org/10.1158/1538-7445.AM2020-320
Published: 15 August 2020
View article titled, Abstract 320: 3D-bioprinting of biomimetic multicellular glioblastoma tissues enable modeling of tumor-immune interactions
Journal Articles

Abstract 3256: TIGIT humanized BALB/c mouse: A novel animal model for preclinical studies of human TIGIT antibodies

Cunxiang Ju, Mingkun Zhang, Xiaoliu Yang, Song Li, Hongyan Sun, Shuai Li, Jing Tang, Jing Zhao, Xiang Gao
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 3256.
https://doi.org/10.1158/1538-7445.AM2020-3256
Published: 15 August 2020
View article titled, Abstract 3256: TIGIT humanized BALB/c mouse: A novel animal model for preclinical studies of human TIGIT antibodies
Journal Articles

Abstract 5627: BALB/c-hCD3E transgenic mice to evaluate humanCD3-bispecific antibodies

Cunxiang Ju, Mingkun Zhang, Dongjing Jia, Rui Mao, Jing Tang, Shuai Li, Jing Zhao, Xiang Gao
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5627.
https://doi.org/10.1158/1538-7445.AM2020-5627
Published: 15 August 2020
View article titled, Abstract 5627: BALB/c-hCD3E transgenic mice to evaluate humanCD3-bispecific antibodies
Journal Articles

Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients

Liye He, Jing Tang, Emma I. Andersson, Sanna Timonen, Steffen Koschmieder, Krister Wennerberg, Satu Mustjoki, Tero Aittokallio
Journal: Cancer Research
Series: Author Choice
Cancer Res (2018) 78 (9): 2407–2418.
https://doi.org/10.1158/0008-5472.CAN-17-3644
Published: 30 April 2018
View article titled, Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
Open the PDF for Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients in another window
Includes: Supplementary data
Journal Articles

Abstract 3746: Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells from ascites

Astrid Murumägi, Akira Hirasawa, Mariliina Arjama, Katja Välimäki, Bhagwan Yadav, Jing Tang, Agnieszka Szwajda, Laura Turunen, John Patrick Mpindi, Teijo Pellinen, Krister Wennerberg, Ralf Bützow, Tero Aittokallio, Olli Kallioniemi
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3746.
https://doi.org/10.1158/1538-7445.AM2015-3746
Published: 01 August 2015
View article titled, Abstract 3746: Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells from ascites
Journal Articles

CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling

Feng Jiang, Lei Chen, Ying-Cheng Yang, Xian-ming Wang, Ruo-Yu Wang, Liang Li, Wen Wen, Yan-Xin Chang, Cai-Yang Chen, Jing Tang, Gao-Mi-Yang Liu, Wen-Tao Huang, Lin Xu, Hong-Yang Wang
Journal: Cancer Research
Cancer Res (2015) 75 (7): 1470–1481.
https://doi.org/10.1158/0008-5472.CAN-14-1589
Published: 31 March 2015
View article titled, CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling
Open the PDF for CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling in another window
Includes: Supplementary data
Journal Articles

Abstract 5220: Identifying AML-specific key targeted drugs using high-throughput drug sensitivity and resistance testing profiles of AML cells.

Disha Malani, Astrid Murumägi, Tea Pemovska, Bhagwan Yadav, Evgeny Kulesskiy, Jing Tang, John Patrick Mpindi, Maija Wolf, Riikka Karjalainen, Tero Aittokallio, Caroline Heckman, Kimmo Porkka, Krister Wennerberg, Olli Kallioniemi
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5220.
https://doi.org/10.1158/1538-7445.AM2013-5220
Published: 15 April 2013
View article titled, Abstract 5220: Identifying AML-specific key targeted drugs using high-throughput drug sensitivity and resistance testing profiles of AML cells.
Journal Articles

Long-term outcome of CD34+ cell transplantation and detection of minimal residual disease in bone marrow using flow cytometry in children with advanced neuroblastoma

Jiao Yang Cai, Yan Jing Tang, Li Min jiang, Jing Yan Tang
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5443.
Published: 01 May 2007
View article titled, Long-term outcome of CD34+ cell transplantation and detection of minimal residual disease in bone marrow using flow cytometry in children with advanced neuroblastoma
Journal Articles

Somatic hypermethylation of Sox7 in prostate cancers

Lizheng Guo, Diansheng Zhong, Xiuju Liu, Xue-Yuan Dong, Xiaodong Sun, Paula Vertino, Carlos Moreno, Jing-Tang Dong, Wei Zhou
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): LB-62.
Published: 01 May 2007
View article titled, Somatic hypermethylation of Sox7 in prostate cancers